ausbiotech 2014
Some of the highlights in the AusBiotech 2014 program
AusBiotech 2014 will be utilising a networking Opening address
Hon. Ian Walker MP
Minister for Science, Information Technology, Innovation and the Arts
Accessing innovation around the world
Dr Sue Dillon
Global Therapeutic Area Head for Immunology for Janssen
The challenges for pharma and biotech in emerging markets - Focus on China and India
Prof Ian Edvalson
Partner, Wilson Sonsini Goodrich Rosati
The connection between medical research and business
Prof Frank Gannon
Director and CEO, QIMR Berghofer Medical Research Institute
The use and future development of biomarkers
Professor Yongzhang Luo
Founder and Chief Scientist, Protgen Ltd
Bench marking biotech: Initiatives for the development of the biotechnology sector in Asia Pacific and their impact
Rhenu Bhuller
Senior Vice President, Healthcare, Frost & Sullivan
Investors unplugged
Chair: Lawrence Gozlan
Chief Executive Officer, Scientia Capital
in the lead-up to and during AusBiotech 2014.
Global regulatory issues
Chair: Bernard O'Shea
Partner Norton Rose Fulbright
The platform can be utilised via your desktop or
New economy, new manufacturing
Chair: Julie Phillips
mobile device, making it easy to continue to interact
Chief Executive Officer, BioDiem
in real time as you keep updated with the latest
What does success look like?
Chair: Rob McInnes
Partner DibbsBarker
information at the conference.
What are we doing for commercialisation in Australia?
Chair: Helen Fisher
Leader - Life Sciences, Deloitte Australia
Translation from innovation to the clinic and beyond
Chair: Dr Mark Ashton
Senior Director, Commercial Engagement, Health, UniQuest
Focus on China
Chair: Glenn Cross
Chief Operating Officer, AusBiotech
Converging the relationship between industry, investors and academia
Chair: Dr Anna Lavelle
Chief Executive Officer, AusBiotech
The changing face of big pharma
Chair: Glenn Cross
Chief Operating Officer, AusBiotech
Introduction of biosimilars into Australia
Chair: Dr Chris Holloway
Founder and Group Director of Regulatory Affairs, ERA Consulting Group
and partnering platform for all participants of the AusBiotech national conference. The powerful application is an integrated mobile event application and business partnering system all in one that will provide delegates with a one-stop shop for all conference information and networking aspects at the conference. The 2014 AusBiotech platform features: • Ability to request and schedule 30-minute meetings with other attendees through the AusPartnering system. • Access to the full program and associated networking events. • Ability to view the profiles for all attendees including, speakers, sponsors, exhibitors and attendees. • Manage a personalised calendar of sessions, meetings and networking events. • Receive important updates and announcements
All full conference attendees have been able to gain access into the AusPartnering system since the end of September 2014. Public forum - can we make brain diseases of ageing a thing of the past? ‘Perspectives on dementia and Alzheimer’s and biotechnology’s role in treatments and prevention’ is a free event for the public to join and hear from a number of experts who will present their vision on what the future of cognitive diseases like dementia and Alzheimer’s looks like. The forum will be held on Friday, 31 October from 9.45 am to noon. All attendees must have their AusBiotech 2014 conference registration, exhibitor pass or public forum pass to attend. Concurrent agriculture and food biotechnology symposium Where is Australia’s global niche? - noon • Room 8, Gold Coast Convention & Exhibition Centre • More information and registration: ausbiotechnc.
• Technological advances that will transform livestock, horticulture and cropping industries. • How to navigate regulatory and legal barriers. • Emerging and enabling biotechnologies. An outstanding line-up of international and
org/program14/AFBS
national speakers from research and development,
This two-day agriculture and food biotechnology
business, commercialisation, and legal and regulatory
symposium will highlight how Australian food and
backgrounds will explain how Australia’s food and
agricultural companies can capitalise on biotechnology
agri-bio industry can secure its future as a niche
innovations by exploring:
provider of technology, services and products and how
• Macroeconomics of influencing Australia’s agri-bio industry.
© freeimages.com/profile/nkzs
• Thursday 30 - Friday 31 October 2014 | 9 am
Australian food and agri-bio companies can position themselves as the preferred providers.
www.LabOnline.com.au | www.LifeScientist.com.au
LAB+LIFE SCIENTIST - October 2014 | 35